RESEARCH
Peer reviewed scientific video journal
Video encyclopedia of advanced research methods
Visualizing science through experiment videos
EDUCATION
Video textbooks for undergraduate courses
Visual demonstrations of key scientific experiments
BUSINESS
Video textbooks for business education
OTHERS
Interactive video based quizzes for formative assessments
Products
RESEARCH
JoVE Journal
Peer reviewed scientific video journal
JoVE Encyclopedia of Experiments
Video encyclopedia of advanced research methods
EDUCATION
JoVE Core
Video textbooks for undergraduates
JoVE Science Education
Visual demonstrations of key scientific experiments
JoVE Lab Manual
Videos of experiments for undergraduate lab courses
BUSINESS
JoVE Business
Video textbooks for business education
Solutions
Language
English
Menu
Menu
Menu
Menu
DOI: 10.3791/63419-v
Sebastian Bass-Stringer1,2, Colleen J. Thomas2,3, Clive N. May3, Paul Gregorevic4, Kate L. Weeks1,5,6, Julie R. McMullen1,2,5,6,7
1Baker Heart and Diabetes Institute, 2Department of Physiology, Anatomy and Microbiology,La Trobe University, 3Florey Institute of Neuroscience and Mental Health,University of Melbourne, 4Department of Physiology, Centre for Muscle Research (CMR),The University of Melbourne, 5Department of Diabetes, Central Clinical School,Monash University, 6Baker Department of Cardiometabolic Health,The University of Melbourne, 7Department of Physiology and Department of Medicine Alfred Hospital,Monash University
This study addresses the challenge posed by preexisting antibodies that neutralize AAV, which hinder the advancement of AAV gene therapies. A cost-effective and straightforward colorimetric assay is developed to detect neutralizing antibodies against AAV6, using HT1080 cells as the model system.
A comprehensive laboratory protocol and analysis workflow are described for a rapid, cost-effective, and straightforward colorimetric cell-based assay to detect neutralizing elements against AAV6.
Preexisting antibodies that neutralize AAV pose a barrier to the advancement of AAV gene therapies. This assay is a screening tool to detect neutralizing antibodies against AAV. The main advantage is that it's cost-effective, time efficient, easy to set up, and requires minimal technical skills, lab equipment, and reagents.
Start plating HT1080 cells on day one by diluting the cells to a concentration of 1 x 10 to the fifth cells per milliliter in pre-warmed complete DMEM media. Then seed 100 microliters of cells per well into clear 96-well flat bottomed plates to the concentration of 1 x 10 to the fourth cells per well. Incubate the plate at 37 degrees Celsius with 5%carbon dioxide overnight for 16 to 22 hours.
View the full transcript and gain access to thousands of scientific videos
View the full transcript and gain access to thousands of scientific videos
Related Videos
11:02
Related Videos
18.6K Views
12:25
Related Videos
26.4K Views
14:48
Related Videos
44.3K Views
08:29
Related Videos
14K Views
08:20
Related Videos
20.7K Views
12:40
Related Videos
15.3K Views
09:39
Related Videos
15.8K Views
12:31
Related Videos
15.7K Views
10:05
Related Videos
9.9K Views
06:27
Related Videos
5.9K Views